GC Aesthetics’ PERLE breast implants proven safe and effective in new independent study

In a significant development in the field of aesthetic surgery, GC Aesthetics (GCA), a leading medical technology company specializing in aesthetic and reconstruction solutions, has announced a major milestone. The company’s innovative product, PERLE, a round smooth opaque breast implant, has been the subject of a recent independent peer-reviewed article in the Aesthetic Surgery Journal Open Forum. This marks the first time clinical data on PERLE is published internationally, underscoring the product’s safety and efficacy.

The study, spearheaded by renowned UK-based surgeon Taimur Shoaib of La Belle Forme in Glasgow, involved a comprehensive analysis of 374 patients over an 18-month period. The findings are groundbreaking, demonstrating low complication rates with the use of PERLE implants. “Our study showed that the safety profile of these implants is comparable with other modern implants with no implant related complications and no cases of capsular contracture,” stated Mr. Shoaib.

This research not only affirms the high quality of PERLE implants but also reinforces GC Aesthetics’ reputation as a pioneer in healthcare solutions. The unique Bio-Q surface and 6th generation gel of PERLE implants have set new standards in the industry, offering both surgeons and patients a reliable and effective option for aesthetic surgery.

Chris Brotherston, Head of Quality, Regulatory and Clinical Affairs at GC Aesthetics, expressed his satisfaction with the findings. “This is not just a milestone for GC Aesthetics; it’s a validation of our commitment to safety and delivering outstanding results. We are also proud to announce the initiation of our 10-year prospective study on PERLE in Q1 of 2024, to continue collecting critical data and to extend its safety and enhanced compatibility profile.”

This independent clinical study is a testament to the ongoing innovation and dedication to excellence in the medical technology sector. As GC Aesthetics continues to evolve and contribute to the global healthcare market, the PERLE breast implant stands as a beacon of quality and safety in aesthetic surgery.

The independent validation of GC Aesthetics’ PERLE breast implants marks a significant advancement in the field of aesthetic surgery. It not only enhances the confidence of surgeons and patients in the product but also sets a new benchmark for clinical safety and performance in the industry. The commitment of GC Aesthetics to ongoing research, as evidenced by their forthcoming 10-year prospective study, further underscores the company’s dedication to innovation and excellence in healthcare solutions.